Welcome to the Investor Relations section of CareFusion’s website. Here, we provide access to a variety of shareholder materials, including financial and stock information, corporate governance resources and access to our presentations and events. We are committed to providing you with convenient access to these resources, and if you need additional information, please contact us.
You can also sign up to receive email alerts when new company information is available by going to CareFusion’s Email Alerts page.
To receive printed copies of CareFusion investor materials by mail, you can submit an on-line request here. You may also send an email to firstname.lastname@example.org with your contact information and material request.
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve patient care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and LTV® series of ventilators and respiratory products, ChloraPrep® skin prep products, MedMined™ services for data mining surveillance, and V. Mueller® and Snowden-Pencer® surgical instruments.
|There are currently no events scheduled.|
View all of CareFusion’s Events & Presentations.
Annual Meeting and Proxy Information
Learn more about CareFusion Annual Meeting of Stockholders and access our Annual Report and Proxy Statement here.
Access more detailed stock information.
|11/18/13||CareFusion To Acquire Vital Signs Division of GE Healthcare For $500 Million|
|Acquisition creates global leader in consumable medical products for respiratory care and anesthesiology
- CareFusion to host investor call at 6 a.m. Pacific Time
SAN DIEGO, Nov. 18, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced the signing of a definitive agreement for CareFusion to acquire the Vital Signs division of GE Healthcare for $500 million.
With annual revenue of approximately $250 million, Vital Signs is a lead... |
|11/07/13||CareFusion Reports First Quarter Fiscal 2014 Results|
|- Revenue of $830 million consistent with company expectations
- Diluted earnings per share (EPS) from continuing operations totaled $0.36 on a GAAP basis and remained even with prior year at $0.44 per adjusted share
- Repurchased 3.3 million shares during the quarter, bringing the company's total investments in share repurchases to $621 million since February 2012
SAN DIEGO, Nov. 7, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today r... |
|10/09/13||CareFusion To Report First Quarter Fiscal 2014 Results On Nov. 7|
|SAN DIEGO, Oct. 9, 2013 /PRNewswire/ -- CareFusion Corporation (NYSE: CFN) today announced plans to release first quarter fiscal 2014 results on Thursday, Nov. 7, following the close of trading on the New York Stock Exchange.
The company will host a conference call on Nov. 7 at 2 p.m. PST (5 p.m. EST) to discuss the results for its first quarter fiscal 2014, ended Sept. 30, 2013. To access the call, visit the Investors page at www.carefusion.com. Log on at least 15 minutes before the call beg... |
|08/08/13||CareFusion Reports Fourth Quarter And Fiscal 2013 Results|
|- Fourth quarter revenue of $903 million in line with company expectations; Fiscal 2013 revenue of $3.55 billion.
- Fourth quarter GAAP diluted earnings per share (EPS) from continuing operations increased 20 percent to $0.49, or 10 percent to $0.55 on an adjusted basis.
- Fiscal 2013 GAAP diluted EPS from continuing operations increased 9 percent to $1.74, or $2.12 on an adjusted basis.
- Company expects fiscal 2014 adjusted diluted EPS in the range of $2.30 to $2.40; Announces $750 mi... |
Read all of
CareFusion’s financial news releases.
Read CareFusion’s news releases.
Cautions Concerning Forward-Looking Statements: This website contains statements that are forward-looking and consequently are subject to risks and uncertainties. Examples of these statements include statements regarding our financial guidance, our expectations regarding hospital capital spending, our expected standup costs and other costs related to the separation from Cardinal Health and other statements regarding matters that are not historical facts. You should be aware that certain factors may affect us in the future and could cause actual results to differ materially from those expressed in these forward-looking statements. Such factors include the risk factors set forth in our Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission (including all amendments to those reports) and exhibits to those reports. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement to reflect subsequent events or circumstances.
Print Page : Email Page : : Sign up for news : Contact Information : Tear Sheet